In vitro alteration of physiological parameters do not hamper the growth of human multipotent vascular wall-mesenchymal stem cells

In vitro alteration of physiological parameters do not hamper the growth of human multipotent vascular wall-mesenchymal stem cells

Background: Mesenchymal stem cells (MSCs) with multilineage potential and anti-inflammatory property can be isolated from different human tissues, representing promising candidates in regenerative medicine. Despite the common criteria of characterization, many factors contribute to MSC heterogeneity...

Full description

Bibliographic Details
Main Authors:	Ciavarella, Carmen (Author), Fittipaldi, Silvia (Contributor), Pedrini, Silvia (Author), Vasuri, Francesco (Author), Gallitto, Enrico (Author), Freyrie, Antonio (Author), Stella, Andrea (Author), Pasquinelli, Gianandrea (Author), Gostjeva, Elena V. (Contributor)
Other Authors:	Massachusetts Institute of Technology. Department of Biological Engineering (Contributor)
Format:	Article
Language:	English
Published:	Frontiers Research Foundation, 2015-08-20T15:37:57Z.
Subjects:	Article
Online Access:	Get fulltext

Similar Items

Paradoxical adverse culture conditions do not hamper the growth of human multipotent vascular wall-mesenchymal stem cells.
by: Carmen eCiavarella, et al.
Published: (2015-06-01)

The crosstalk between vascular MSCs and inflammatory mediators determines the pro-calcific remodelling of human atherosclerotic aneurysm
by: Carmen Ciavarella, et al.
Published: (2017-04-01)

Involvement of miR-30a-5p and miR-30d in Endothelial to Mesenchymal Transition and Early Osteogenic Commitment under Inflammatory Stress in HUVEC
by: Carmen Ciavarella, et al.
Published: (2021-02-01)

The study of calcified atherosclerotic arteries: an alternative to evaluate the composition of a problematic tissue reveals new insight including metakaryotic cells
by: Fittipaldi, Silvia, et al.
Published: (2016)

Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells Derived from Human Arteries: A Novel Strategy to Accelerate Vascular Ulcer Wound Healing
by: Sabrina Valente, et al.
Published: (2016-01-01)

Adventitial Microcirculation Is a Major Target of SARS-CoV-2-Mediated Vascular Inflammation
by: Francesco Vasuri, et al.
Published: (2021-07-01)

ETS-Related Gene Expression in Healthy Femoral Arteries With Focal Calcifications
by: Francesco Vasuri, et al.
Published: (2021-06-01)

In Vitro Generation of Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature from Murine Induced Pluripotent Stem Cells
by: Jennifer Steens, et al.
Published: (2017-04-01)

Adult Vascular Wall Resident Multipotent Vascular Stem Cells, Matrix Metalloproteinases, and Arterial Aneurysms
by: Bruno Amato, et al.
Published: (2015-01-01)

Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro
by: Pasquinelli Gianandrea, et al.
Published: (2007-02-01)

Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature within the Process of Vascular Remodeling: Cellular Basis, Clinical Relevance, and Implications for Stem Cell Therapy
by: Diana Klein
Published: (2016-01-01)

Diffuse Calcifications Protect Carotid Plaques regardless of the Amount of Neoangiogenesis and Related Histological Complications
by: Francesco Vasuri, et al.
Published: (2015-01-01)

Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells
by: Handgretinger Rupert, et al.
Published: (2010-01-01)

Multipotent mesenchymal stem cells in renal transplantation
by: N. V. Borovkova, et al.
Published: (2019-03-01)

Multipotent mesenchymal stem cells in lung fibrosis.
by: Katrin E Hostettler, et al.
Published: (2017-01-01)

Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?
by: Guido Moll, et al.
Published: (2014-01-01)

Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
by: Carmen Ciavarella, et al.
Published: (2020-04-01)

Correction: Multipotent mesenchymal stem cells in lung fibrosis.
by: PLOS ONE Staff
Published: (2018-01-01)

Neural differentiation of canine mesenchymal stem cells/multipotent mesenchymal stromal cells
by: Sonja Prpar Mihevc, et al.
Published: (2020-08-01)

The Lack of a Representative Tendinopathy Model Hampers Fundamental Mesenchymal Stem Cell Research
by: Marguerite Meeremans, et al.
Published: (2021-05-01)

ROLE OF MESENCHYMAL MULTIPOTENT STROMAL CELLS IN REMODELING OF BONE DEFECTS
by: M. V. Kiselevsky, et al.
Published: (2018-06-01)

Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?
by: Pascal David Johann, et al.
Published: (2015-01-01)

Comparative Quantification of the Surfaceome of Human Multipotent Mesenchymal Progenitor Cells
by: Rebecca J. Holley, et al.
Published: (2015-03-01)

Multivariate biophysical markers predictive of mesenchymal stromal cell multipotency
by: Lee, Wong Cheng J., et al.
Published: (2015)

Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
by: Arseniy A. Lobov, et al.
Published: (2020-11-01)

The adult human brain harbors multipotent perivascular mesenchymal stem cells.
by: Gesine Paul, et al.
Published: (2012-01-01)

Derivation of multipotent mesenchymal precursors from human embryonic stem cells.
by: Tiziano Barberi, et al.
Published: (2005-06-01)

Derivation of multipotent mesenchymal precursors from human embryonic stem cells.
Published: (2005-06-01)

Functional Characteristics of Multipotent Mesenchymal Stromal Cells from Pituitary Adenomas
by: Kaspars Megnis, et al.
Published: (2016-01-01)

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
by: Sytwu Huey-Kang, et al.
Published: (2011-07-01)

ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells
by: Tompkins Kathleen, et al.
Published: (2010-10-01)

The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids
by: Yuriy Petrenko, et al.
Published: (2017-04-01)

Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver.
by: Reto M Baertschiger, et al.
Published: (2009-08-01)

Obtaining hepatocytes by transdifferentiation of multipotent mesenchymal stromal cells by genetic engineering
by: Makeyev Oleg, et al.
Published: (2020-01-01)

The Utilization of Multipotent Mesenchymal Stromal Cell Transplantation to Improve Fascia Repair
by: Bown, Andre B. J.
Published: (2013)

Growth Factor-Mediated Tenogenic Induction of Multipotent Mesenchymal Stromal Cells Is Altered by the Microenvironment of Tendon Matrix
by: Susanne Pauline Roth, et al.
Published: (2018-10-01)

HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells
by: Pasquinelli Gianandrea, et al.
Published: (2011-05-01)

Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth.
by: Catherine To, et al.
Published: (2014-01-01)

Cytomegalovirus Infection Impairs Immunosuppressive and Antimicrobial Effector Functions of Human Multipotent Mesenchymal Stromal Cells
by: Roland Meisel, et al.
Published: (2014-01-01)

Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells
by: Alexandre T. J. Maria, et al.
Published: (2018-11-01)